Progesterone Capsule
Product Images NDC 76420-580

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 76420-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure001)

Graph1 (Figure001)
A line graph depicting the probability of hyperplasia over 36 months for patients on different medication regimens. The x-axis shows time in months on medication, with patient counts at intervals noted, while the y-axis shows probability of hyperplasia. Lines represent Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only groups, illustrating differences in hyperplasia probability over time.*
FDA Label Image

100 mg Capsules (Progesterone Image001 V1)

100 mg Capsules (Progesterone Image001 V1)
Labels for Progesterone Capsules 100 mg by Enovachem Pharmaceuticals, packaged in quantities of 30, 60, 90, and 100 capsules. Each label includes NDC numbers, packaging and manufacturing details, barcodes, and cautionary storage instructions. Capsules are described as yellow, oval, opaque, and of prescription drug status.*
FDA Label Image

200 mg Capsules (Progesterone Image002 V1)

200 mg Capsules (Progesterone Image002 V1)
Four packaging labels for Progesterone Capsules 200 mg, oral dosage form, labeled by Enovachem Pharmaceuticals with address in Torrance, CA. Each label shows a different package quantity: 30, 60, 90, and 100 capsules. They include the NDC numbers, barcodes, QR codes, and cautionary storage and prescription information. Manufactured for Bionpharma Inc., the capsules are described as white, oval, opaque. Drug status is RX in all labels.*
FDA Label Image

Chemical Structure (Structure)

Chemical Structure (Structure)
Chemical structure diagram of progesterone, illustrating its molecular configuration with carbon rings, methyl groups, and ketone functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.